Customize
Quick Links
Specialties

Accreditation/Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca; Biocept, Inc; Foundation Medicine, Inc; Genomic Health; Guardant Health; and Novartis Pharmaceuticals Corporation.

Community Practice Connections: Precision Medicine Through Plasma: Using Liquid Biopsies in Contemporary Oncology Care


Release Date: January 31, 2018
Expiration Date: January 31, 2019
Media: Internet - based

 

Activity Overview

Successful patient selection and implementation of tumor interrogation methods, including such emerging technologies as liquid biopsies, are essential to providing timely, accurate characterization of different types of solid tumors, which can have a tremendous influence on treatment selection, and, ultimately, patient outcomes. Precision Medicine Through Plasma: Using Liquid Biopsies in Contemporary Oncology Care is being launched to address the rapidly evolving science and associated therapeutic developments resulting from the emergence of such novel testing strategies as liquid biopsies. In this half-day symposium, key experts in lung, breast, and gastrointestinal malignancies will provide an overview of the latest clinical data on liquid biopsies, followed by detailed case discussions with a multidisciplinary faculty.

Acknowledgement of Commercial Support

This activity is supported by educational grants from AstraZeneca; Biocept, Inc; Foundation Medicine, Inc; Genomic Health; Guardant Health; and Novartis Pharmaceuticals Corporation.

CME/CE Activity Table of Contents

  • Expert Perspective on Liquid Biopsy
  • Expert Perspective on Liquid Biopsy in Lung Cancer
  • Expert Perspective on Liquid Biopsy in Breast Cancer
  • Expert Perspective on Liquid Biopsy in Gastrointestinal Cancer

Instructions for This Activity and Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, “educational content/video files” will be available for your reference.
  • In order to receive a CME/CE certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME/CE certificate upon completion of these steps.


Target Audience

This educational activity is intended for medical oncologists, pathologists, and fellows who treat patients with cancer. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of cancer are also invited to participate.

Learning Objectives

At the conclusion of this activity, you should be better prepared to:

  • Compare the relative strengths and limitations of liquid biopsy against those of conventional tissue biopsy
  • Identify the scientific foundations of liquid biopsy technology
  • Contrast available and emerging testing technologies with respect to sensitivity, specificity, and clinical applications for patients with cancer
  • Appraise clinical evidence pertaining to specific testing modalities that may help to individualize treatment protocols for patients with cancer

Faculty, Staff, and Planners' Disclosures

Chair

Benjamin Levy, MD
Clinical Director of Medical Oncology
Johns Hopkins Sidney Kimmel Cancer Center
Sibley Memorial Hospital
Washington, DC
 

Disclosure: Consultant: Genentech, Eli Lilly, AstraZeneca, Celgene, Bristol-Myers Squibb, Merck

Faculty

Ryan B. Corcoran, MD, PhD
Director, Gastrointestinal Cancer Center Program
Massachusetts General Hospital Cancer Center
Boston, MA
 
 

Disclosure: Consultant: Genentech, Merrimack, Taiho, Avidity NanoMedicines, Astex, Roche, Bristol-Myers Squibb, FogPharma, Loxo Oncology, Amgen

Geoffrey R. Oxnard, MD
Associate Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Boston, MA
 

Disclosure: Consultant: AstraZeneca, Takeda, Inivata, DropWorks; Other: Honoraria from Sysmex, Guardant Health

Heather A. Parsons, MD, MPH
Instructor in Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Boston, MA
 

Disclosure: No relevant financial relationships with commercial interests to disclose

The staff of PER® have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME/CE activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.







Become a Member

Forgot Password?
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
  12345
6789101112
13141516171819
20212223242526
2728293031
Filter By